ロード中...
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial
BACKGROUND: Hohla et al. suggested that female gender could positively predict response to FOLFIRINOX in patients with advanced pancreatic cancer. In this study, we explored the response to the FOLFIRINOX regimen by gender within the trial PRODIGE4/ACCORD 11. PATIENTS AND METHODS: Data were describe...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5606928/ https://ncbi.nlm.nih.gov/pubmed/28931010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0183288 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|